Therefore, this open-label, single-arm phase II clinical trial aims to investigate the efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating HCC patients with ...

Hereditary leiomyomatosis and renal-cell cancer (HLRCC) is an inherited disorder characterized by germline pathogenic variants in the gene encoding fumarate hydratase and an increased risk of ...

Please provide your email address to receive an email when new articles are posted on . First-line anlotinib plus chemotherapy had noninferior PFS to bevacizumab plus chemotherapy for certain ...

An interaction can occur because one substance causes another substance to have a different effect than expected. Interactions can also occur if you have certain health conditions. Keep reading to ...

The US Food and Drug Administration (FDA) has approved bevacizumab-nwgd (Jobevne, Biocon Biologics Ltd), a biosimilar to bevacizumab (Avastin, Genentech), for intravenous use across multiple cancer ...

Credit: Biocon Biologics. Jobevne, a vascular endothelial growth factor inhibitor, was approved as a biosimilar to Avastin. Pharmacokinetic, safety, efficacy, and immunogenicity data showed Jobevne ...

Pharmacokinetic, safety, efficacy, and immunogenicity data showed Jobevne was similar to the reference product. The approval was supported by a comprehensive clinical package, which included ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a wide variety of off-label indications and add hundreds of millions of dollars ...

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers While the addition of ...